FDA
approval
· 2018-01-22
FDA Approved: SPRIX — Supplemental Application (Zyla Life Sciences US LLC)
Summary
The FDA approved a supplemental application for SPRIX (ketorolac tromethamine) filed by Zyla Life Sciences US LLC. This approval pertains to changes associated …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for SPRIX (KETOROLAC TROMETHAMINE)